<?xml version='1.0' encoding='utf-8'?>
<document id="20645002"><sentence text="Potential drug-drug interactions between anti-cancer agents and community pharmacy dispensed drugs." /><sentence text="To identify the prevalence of potential drug-drug interactions between hospital pharmacy dispensed anti-cancer agents and community pharmacy dispensed drugs" /><sentence text="" /><sentence text="A retrospective cohort study was conducted on the haematology/oncology department of the internal medicine ward in a large teaching hospital in Amsterdam, the Netherlands" /><sentence text="" /><sentence text="Prescription data from the last 100 patients treated with anti-cancer agents were obtained from Paracelsus, the chemotherapy prescribing system in the hospital" /><sentence text=" The community pharmacy dispensed drugs of these patients were obtained by using OZIS, a system that allows regionally linked pharmacies to call up active medication on any patient" /><sentence text=" Both medication lists were manually screened for potential drug-drug interactions by using several information sources on interactions, e" /><sentence text="g" /><sentence text=" Pubmed, the Flockhart P450 table, Micromedex and Dutch reference books" /><sentence text="" /><sentence text="Prevalence of potential drug-drug interactions between anti-cancer agents provided by the hospital pharmacy and drugs dispensed by the community pharmacy" /><sentence text="" /><sentence text="Ninety-one patients were included in the study" /><sentence text=" A total of 31 potential drug-drug interactions were found in 16 patients, of which 15 interactions were clinically relevant and would have required an intervention" /><sentence text=" Of these interactions 1 had a level of severity ≥ D, meaning the potential drug-drug interaction could lead to long lasting or permanent damage, or even death" /><sentence text=" The majority of the interactions requiring an intervention (67%) had a considerable level of evidence (≥ 2) and were based on well-documented case reports or controlled interaction studies" /><sentence text=" Most of the potential drug-drug interactions involved the antiretroviral drugs (40%), proton pump inhibitors (20%) and antibiotics (20%)" /><sentence text=" The anti-cancer drug most involved in the drug-drug interactions is methotrexate (33%)"><entity charOffset="69-81" id="DDI-PubMed.20645002.s19.e0" text="methotrexate" /></sentence><sentence text="" /><sentence text="This study reveals a high prevalence of potential drug-drug interactions between anti-cancer agents provided by the hospital pharmacy and drugs dispensed by the community pharmacy" /><sentence text=" It shows us there is need for an optimal medication surveillance mechanism to detect potential drug-drug interactions between these two groups of medication, especially because of the high toxicity of anticancer drugs and thus the severe consequences these interactions can have for the patient" /><sentence text="" /></document>